Background Countries with population-based colorectal cancer screening using faecal occult blood test kits performed in the home and posted to the laboratory struggle to achieve higher than 60% uptake. We measured the impact on participation of offering a community laboratory drop-off (CLD) alternative to postal return in New Zealand's Bowel Screening Pilot.
Introduction
Although there is good evidence that colorectal cancer screening by faecal occult blood detection is effective at preventing deaths from bowel cancer, 1 the impact of screening programmes has been limited by low participation rates with few programmes achieving uptake above 60%. 2 In January 2012 New Zealand commenced a pilot of bowel screening for all men and women aged 50-74 years in Waitemata District (eligible population~153 000). Although the pilot is considered to have been highly successful, achieving an overall participation rate of 56.8% in the first round of screening, the participation rate for Māori and Pacific ethnic groups was significantly lower (46 and 30.4%, respectively). 3 Participation is also lower for men and it increases steadily with age.
From the beginning of the programme there was a strong commitment to reducing the screening inequities that exist between different population groups and a number of different strategies have been implemented or tested to increase participation of the Māori and Pacific groups in particular. These include careful redesign of invitation letters and test kit instructions, community engagement activities, an ongoing active follow-up service to contact Māori, Pacific and Asian participants who fail to return a test kit with 4 weeks of having been sent an invitation, and a strategy to allow opportunistic support by general practitioners (GPs) to facilitate participation, with monetary payments to the GP when test kits are returned by their patients from low participation ethnic groups.
One of the strategies trialed was an option to drop the completed test kit off at a community laboratory instead of posting it in the mail. Maori and Pacific advisors have suggested that posting a faecal sample to a laboratory may be unacceptable to their population groups for cultural reasons, and this was supported by independent research commissioned by the Bowel Screening Coordination Centre (unpublished). We report the findings of an interrupted time-series evaluation of an intervention to permit bowel screening invitees to drop their test kits off at one of a number of community laboratories. We believe that these results will be of interest to other bowel screening programmes.
Methods
For practical reasons it was decided that a randomised controlled trial would not be feasible and that the 5-month trial of offering a community laboratory drop-off (CLD) option for test kits would be evaluated by non-experimental methods, namely interrupted time series analysis (ITSA). The New Zealand Health and Disability Ethics Committee (HDEC) tool was used to assess the study and it was determined that a formal ethical review by HDEC was not required on the grounds that this met the definition of a health service audit with very low risk of harm, and did not involve collection of human tissue, and in which no individuals' health information would be used in a form that would allow their identification by the researchers.
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Study population
All eligible individuals invited to bowel screening were included. The eligibility criteria are age 50-74 years, no previous conditions and no colonoscopy in the preceding 5 years.
Intervention
The usual procedure for returning a completed bowel screening kit involves the participant using a prepaid envelope to send the completed test kit by post to the laboratory where it is analysed. From 1 May to 30 September 2015 an additional flier was included in all test kits. Figure 1 shows the front page of the flier. The reverse side (not included here) was a list of the addresses where the kit could be dropped off. The flier stated that the participant could choose one of two ways to return their kit-by post or via a community collection centre. It was translated into Maori, Samoan, Tongan, Chinese and Korean. No other change was made to the materials sent to prospective participants. Kits could be dropped off at any one of the 22 collection rooms in the District belonging to Labtests Ltd, the contracted provider of community laboratory services for the Waitemata District. Labtests delivered these samples to LabPlus (the bowel screening pilot contracted laboratory) on a daily basis using the established process for other samples. Kits which arrived at LabPlus via the Labtests courier were opened and registered as usual. However, the consent forms with these kits were marked with a sticker to differentiate them from the kits returned by mail. The trial intervention population comprised all eligible individuals invited to bowel screening between 1 May and 30 September 2015 (21 weeks and 6 days).
Outcome measure
The outcome measure used was the screening participation rate (The terms participation rate and participant are used in this article to refer to participation in screening, not in the study itself.), defined as the number of individuals returning a specimen within 139 days (i.e.~4 and a half months) of invitation, divided by the total number of invitees. A nonparticipant was someone who never returned a completed kit or did not do so within 139 days. This cutoff represented the time after the trial that the bowel screening team stopped recording CLD returns.
Study design and statistical analysis
Bowel screening participation rates for the CLD trial period were compared with the period before and after the trial using Interrupted Time Series Analysis (ITSA). ITSA is a quasi-experimental research design with the potential for a high degree of internal validity. 6 It is particularly useful for evaluating population level health interventions that are implemented at a clearly defined point in time and it has been used to assess the impact of a wide range of interventions. 7 An interrupted time series follows a time trend at a population unit of analysis level, in a particular outcome measure that is 'interrupted' by the introduction of an intervention of some sort or another at a known point in time. The period included in the study ran from 28 November 2014 to 3 March 2016, of which the intervention period ran 1 May 2015 until 30 September 2015. The pre-intervention trend is used as the counter-factual against which to test whether there has been a significant change in the level or trend in the outcome variable. ITSA is an appropriate method to assess the impact of the CLD intervention because this occurred at a clearly defined time point, the outcome (participation rate) was expected to change immediately, and because the intervention was introduced and then withdrawn again.
Existing data collections systems, which did not change over the study period were able to collect the outcomes with a high degree of accuracy.
It was hypothesized that the introduction of CLD would lead to an immediate step increase in participation rate, and that this would be highest for those population groups for whom postal return of a test kit was considered to be least culturally acceptable (i.e. Māori and Pacific). It was further hypothesized that the level change in participation rate would be the same when the intervention was withdrawn as when it was introduced, and that any underlying trend in participation rates would not be changed by the intervention. A level change regression model was therefore fitted.
where Y t is the participation rate at time t; T is the time period measured in weeks; β 2 represents the change in participation rate associated with introducing and removing the CLD option (dummy variable X t ); the underlying trend in participation is modelled as a straight line of slope β 1 and intercept β 0 ; and the residual is e.
The ITSA analysis was performed in Stata ® 13 using the 'newey' command with a lag of 1 week. This produced Newey-West standard errors that allow for potential autocorrelation between sequential outcome measurements and possible heteroskedasticity. 6 Exploratory analyses found evidence of autocorrelation with a lag of 1 week and therefore the regression models applied this in the autocorrelation structure. To allow for the varying precision in participation rates measurement between time periods due to variation in the number of invitees, the measurements were weighted by the inverse of their variance calculated as follows:
where w i is the analytic weight given to observation i with participation rate p i from a total of n i invitees.
In addition to the ITS analysis, a logistic regression analysis of individual level data was performed, including an effect modification assessment of how the impact of the CLD intervention varies with gender, ethnicity and age. The logistic regression analysis included a continuous time variable to account for linear trend in participation. Effect modification parameters were explored postestimation using linear combinations of coeffecients.
Patients were classified into one of four ethnicity groups: Māori; Pacific; Asian; or European/other. Patients were classified by 'prioritised ethnicity' as recorded in the bowel screening register. This assigns a single ethnicity to individuals who have recorded multiple ethnicities, based on a ranking specified in the national ethnicity standards. 8 Thus, those with Māori as any of their ethnicities are assigned Māori as their prioritised ethnicity. Similarly, those with any Pacific ethnicity code are classed as Pacific, unless they also have a Māori response.
Results
Overall participation numbers and rates, before, during and after the CLD trial are shown in Table 1. The Table reveals the generally lower participation rates among males, Māori, Pacific and invitees under the age of 60. Table 2 shows the utilization of the CLD option and the main results from the ITSA analysis. Overall about a quarter of participants made use of the CLD option and this was reasonably similar in all groups except Asians where it was lower. If we assume that all the observed increases in participation were people using the CLD option, then the proportion of those dropping off test kits at the laboratory who would otherwise have posted their kit ranges from 88% in Pacific to 100% in Asian and Females.
The ITS analysis revealed statistically significant increases in participation among males, Māori and Pacific (as a combined group), European/other and invitees under the age of 60 during the CLD trial. No group experienced a statistically significant drop in participation. The participation trends and the modelled changes during the CLD trial for these subgroups are shown in Fig. 1 . Table 3 presents the results of the logistic regression modelling. In the main effects model, the CLD intervention was found to be statistically significant with an odds ratio of 1.03 after controlling for age, ethnicity, gender and allowing for a linear trend in participation. In the second model age, gender and ethnicity modifications to the effect of the CLD intervention are examined. The differential effect of the intervention in these subgroups is illustrated in Fig. 2 . It was statistically significant only for males aged 50-59 excluding Asians although the magnitude of the odds ratio was similar for older male Māori and Pacific and younger female Māori and Pacific. The CLD option appears to be associated with a significantly lower kit return odds for older female Asians. The results can be interpreted as confirming that the intervention had a significantly greater impact on male and younger invitees except for Asians. Although effect sizes were larger for Māori and Pacific than for European and Other, the confidence limits overlap and there is therefore not a statistically significant difference between the two groups.
Discussion Main findings of this study
The trial has demonstrated that a large minority of participants chose to use the CLD option, but it can be presumed that most of these would have posted their kits if this option were not available. Interestingly, the proportion using the Intervention by Mā ori/Pacific 1.057 0.957-1.167 *P < 0.05, **P < 0.01, ***P < 0.001.
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CLD option did not always reflect the impact on participation. Only 22% of kits were returned to the community laboratory in age group 50-59 compared with 30% in 60-74, but the impact on overall participation was significant for the former but not the latter.
The ITS analysis demonstrates a small but statistically significant increase in participation for those subgroups of the population that generally have lower participation rates (men, Māori and Pacific and invitees under the age of 60). In addition, there is evidence of a small but significant increase in screening participation by the majority European/other ethnic group. The fact that the overall increase in participation was not statistically significant can probably be attributed to heterogeneity in the total population, and to the apparent lack of any effect in the Asian population. The reasons for the absence of an increase in participation in the Asian subgroup and the significantly lower participation among older female Asians during the intervention phase, are not known. Language barriers is one possible explanation even though the flyer was translated into Chinese and Korean.
The higher increase in participation during the CLD trial among those groups with the lowest rates of participation suggests that their screening rates may be being affected by some resistance to returning kits by post or difficulty in doing so. The small scale research commissioned to evaluate the trial found that for many who used the CLD option, their decision was influenced by the conviction that the test was important and that it would be more accurately and quickly performed if the kit were dropped off at the laboratory. 9 A smaller number were concerned about the hygiene aspect of posting a test kit. The high utilisation of the CLD option supports the finding by Phoenix Research that for many it generates a degree of peace of mind, even though most of them would have returned a kit by post if this choice had not been available.
What is already known on this topic
To our knowledge this is the first published research to compare alternative ways to return bowel screening test kits. National and regional population-based screening programmes in a number of other countries (apparently) offer an exclusively postal return method including Sweden, Finland, the Netherlands, Ireland, Scotland, England and Wales, and Australia. These findings may be of relevance to those programmes, most of which struggle to achieve participation rates above 60%. In a comparison of 15 separate screening programmes from 12 different countries the median participation rate was just 43.9%. 2 Although a CLD option may only make a small contribution to increasing uptake in New Zealand, this research does raise the question of whether a significant proportion of other populations may also prefer to use a non-postal mode of returning their test kit and whether this would lead to higher participation in those countries.
Following on from the successful Waitemata pilot, New Zealand is about to embark upon a phased implementation of a national programme of bowel screening. It is hoped that this analysis will provide guidance to those deciding whether a CLD option should be incorporated within the programme.
What this study adds
This study has demonstrated the value of interrupted time series analysis as a non-experimental approach to evaluation. Not e138 JOURNAL OF PUBLIC HEALTH all changes in health services can be evaluated by RCTs, and it is therefore important to have a range of other methods available. ITS are regarded as a quasi-experimental method that are capable of producing treatment effect estimates with strong internal validity. 6, 10 The most common validity threats are other events that have an onset at the same time as the intervention onset and provide a plausible alternative explanation. These may be other interventions, changes in the environment, changes in participants, or changes in methods of collecting outcomes. In this case there were no changes of this sort identified despite careful interrogation of project personal and clinicians, and investigation of available patient data. These threats are also less likely to be important when the intervention is sudden and the onset of its effect is expected to be immediate. 11 In addition outcome data collection was complete and the outcome is objective, which reduces concern about lack of blinding. 12 The only factor that may have contributed was that both pre-and post-intervention periods included the Christmas period when kit return rates may have been lower. This possibility was explored in individual level data by comparing overall return rates including and excluding the 3-week period including Christmas and New Year holidays (results not shown) but this did not materially change the results and conclusions.
Although the observed increases in participation were not particularly large in absolute terms the cost of the two return methods was similar: $1.88 for each Fast Post/Parcel Post envelope sent via mail and $1.80 (handling charge) per test kit for those returned via the CLD option. This means that it was effectively a cost-neutral or potentially even a cost-saving intervention and, therefore its cost-effectiveness will be high in Waitemata, and likely to be so also elsewhere (nationally and internationally) if similar cost differentials and impact on participation can be achieved there. Furthermore, its potentially greater impact on Māori and Pacific could be expected to reduce the ethnic and gender inequalities in participation that have persisted since the outset of the bowel screening pilot. Indeed, the 1.75% increase in participation of males during the trial period would be sufficient to virtually eliminate the current sex difference in bowel screening participation. Given that the intervention was effectively cost neutral, and there was low risk of harm, small increases in screening coverage should be pursued even if the study showed only benefit on the balance of probabilities; in this case the evidence is considerably stronger.
Although an overall statistically significant increase in participation was not observed in the ITS analysis, it was in the main effects logistic regression model. From both analyses it can be concluded that offering a community laboratory dropoff option leads to a small but significant increase in bowel screening participation among non-Asian men and younger invitees-groups that typically exhibit lower rates of participation in bowel screening. Given the low cost of this intervention it would seem sensible to consider incorporating this as standard practice in New Zealand's national bowel screening programme, and also in other countries if it is feasible.
Limitations
The study has not attempted to examine impacts on cancer detection that might accrue from a test kit dropoff option. We have no information to suggest that the additional people screened are at higher or lower risk of bowel cancer and therefore we assumed that these will be proportionate to the increase in participation rate achieved within each of the specific demographic groups.
The ITS analysis involved nine subgroups tested in addition to the overall test which raises the question of whether the significance testing was accurate in the light of this multiple testing. This was less of an issue with the logistic regression model where there were just three additional tests (one for each effect modification). Nevertheless the statistically significant ethnic variation in impact of the CLD intervention needs to be interpreted with some caution, particularly the apparently lower participation rate of older Asians during the intervention period.
Supplementary data
Data (non-identifiable) used in this research are available upon request from the corresponding author.
